Dentons Expects Further Losses in 2013
-
Last Update: 2020-07-01
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
December 30, 2013, Dentons Biochemical Technology Group Co., Ltdissued a 2013 profit and loss warning announcement89g
On the basis of a preliminary review of the Group's unaudited and integrated management departments for the 11 months ended November 30, 2013, the Board of Directors of the Company informed its shareholders and prospective investors that the Company is expected to record further losses as of 31 November 2013 compared with the year ended 31 December 2012, mainly due to the decline in the price and demand of the Group's products and demand, in particular the impact of the Group's product sales on the recent emergence of the New Avian Influenza Virus, and the possible allocation of inventory89g
Due to the challenging market conditions, the Group will continue to take a prudent approach to financial resource management and production operations, while the Group's financial position remains solidWith the lysine industry now in the midst of consolidation and the Group's largest lysine manufacturer, the Directors believe the Group is ready to face all challenges and further strengthen its leadership position as it recovers89gOn December 30, 2013, Dentons Biochemical Technology Group Co., Ltdissued a profit and loss warning announcement for 201389g
On the basis of a preliminary review of the Group's unaudited and integrated management departments for the 11 months ended November 30, 2013, the Board of Directors of the Company informed its shareholders and prospective investors that the Company is expected to record further losses as of 31 November 2013 compared with the year ended 31 December 2012, mainly due to the decline in the price and demand of the Group's products and demand, in particular the impact of the Group's product sales on the recent emergence of the New Avian Influenza Virus, and the possible allocation of inventory89g
Due to the challenging market conditions, the Group will continue to take a prudent approach to financial resource management and production operations, while the Group's financial position remains solid With the lysine industry now in the midst of consolidation and the Group's largest lysine manufacturer, the Directors believe the Group is ready to face all challenges and further strengthen its leadership position as it recovers 89g
Share it on feed
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
